Deutsche Bank
CADL icon

Deutsche Bank’s Candel Therapeutics CADL Stock Holding History

Deutsche Bank’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$163K Buy
33,300
+4,925
+17% +$26.8K ﹤0.01% 3086
2025
Q4 		$160K Buy
28,375
+1,716
+6% +$9.23K ﹤0.01% 3116
2025
Q3 		$136K Buy
26,659
+5,034
+23% +$29.1K ﹤0.01% 3231
2025
Q2 		$109K Sell
21,625
-4,586
-17% -$23.6K ﹤0.01% 3216
2025
Q1 		$148K Sell
26,211
-5,311
-17% -$43.4K ﹤0.01% 3077
2024
Q4 		$274K Buy
31,522
+30,989
+5,814% +$183K ﹤0.01% 2958
2024
Q3 		$3.69K Buy
533
+465
+684% +$2.89K ﹤0.01% 3549
2024
Q2 		$422 Buy
+68
New +$510 ﹤0.01% 3538

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's CADL Position: Q1 2026 in Review

Deutsche Bank increased its Candel Therapeutics (CADL) stake by 17% in Q1 2026, buying an estimated $26.8K and bringing the position to 33,300 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #3086.

Deutsche Bank first reported a position in CADL in Q2 2024 and has held it in 8 quarters since. The position peaked at $274K in Q4 2024. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Deutsche Bank held 33,300 shares of Candel Therapeutics worth $163K as of Q1 2026.
  • Deutsche Bank bought 4,925 Candel Therapeutics shares in Q1 2026, an estimated $26.8K.
  • Candel Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3086 holding.
  • Deutsche Bank first reported a position in Candel Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Deutsche Bank's Candel Therapeutics position peaked at $274K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.